Expression of Mammalian Proteins for Diagnostics and Therapeutics: a Review

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2022 Jun 8

PMID 35674877

Authors

Jacqueline Kar Kei Mark

Crystale Siew Ying Lim

Fazlina Nordin

Gee Jun Tye

Affiliations

Soon will be listed here.

Abstract

Background: Antibodies have proven to be remarkably successful for biomedical applications. They play important roles in epidemiology and medicine from diagnostics of diseases to therapeutics, treating diseases from incessant chronic diseases such as rheumatology to pandemic outbreaks. With no end in sight for the demand for antibody products, optimizations and new techniques must be expanded to accommodate this.

Methods And Results: This review discusses optimizations and techniques for antibody production through choice of discovery platforms, expression systems, cell culture mediums, and other strategies to increase expression yield. Each system has its own merits and demerits, and the strategy chosen is critical in addressing various biological aspects.

Conclusions: There is still insufficient evidence to validate the efficacy of some of these techniques, and further research is needed to consolidate these industrial production systems. There is no doubt that more strategies, systems, and pipelines will contribute to enhance biopharmaceutical production.

Citing Articles

Expression of UCOE and HSP27 Molecular Elements to Improve the Stable Protein Production on HEK293 Cells.

Sosa-Garcia C, Sanchez-Pacheco U, Tavira-Montalvan C, Meneses-Acosta A Biomed Res Int. 2025; 2025:5556353.

PMID: 40041570 PMC: 11879590. DOI: 10.1155/bmri/5556353.

The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics.

Gezehagn Kussia G, Tessema T J Immunol Res. 2024; 2024:1804038.

PMID: 39156005 PMC: 11329312. DOI: 10.1155/2024/1804038.

Application of CRISPR-Cas9 genome editing technology in various fields: A review.

Ansori A, Antonius Y, Susilo R, Hayaza S, Kharisma V, Parikesit A Narra J. 2024; 3(2):e184.

PMID: 38450259 PMC: 10916045. DOI: 10.52225/narra.v3i2.184.

Recombinant Porcine Interferon-α Decreases Pseudorabies Virus Infection.

Song B, Wei W, Liu X, Huang Y, Zhu S, Yi L Vaccines (Basel). 2023; 11(10).

PMID: 37896991 PMC: 10610829. DOI: 10.3390/vaccines11101587.

Recombinant vaccines in 2022: a perspective from the cell factory.

de Pinho Favaro M, Atienza-Garriga J, Martinez-Torro C, Parlade E, Vazquez E, Corchero J Microb Cell Fact. 2022; 21(1):203.

PMID: 36199085 PMC: 9532831. DOI: 10.1186/s12934-022-01929-8.

References

Fernandez-Chacon M, Casquero-Garcia V, Luo W, Lunella F, Ferreira Rocha S, Del Olmo-Cabrera S . iSuRe-Cre is a genetic tool to reliably induce and report Cre-dependent genetic modifications. Nat Commun. 2019; 10(1):2262. PMC: 6531465. DOI: 10.1038/s41467-019-10239-4. View

Vidarsson G, Dekkers G, Rispens T . IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014; 5:520. PMC: 4202688. DOI: 10.3389/fimmu.2014.00520. View

Gomes D, Aragao L, Lima Neto M, Barroso P, Paulino L, Silva B . Supplementation of culture medium with knockout serum replacement improves the survival of bovine secondary follicles when compared with other protein sources during culture. Zygote. 2019; 28(1):32-36. DOI: 10.1017/S0967199419000583. View

Saphire E, Schendel S, Gunn B, Milligan J, Alter G . Antibody-mediated protection against Ebola virus. Nat Immunol. 2018; 19(11):1169-1178. PMC: 6814399. DOI: 10.1038/s41590-018-0233-9. View

Estes S, Melville M . Mammalian cell line developments in speed and efficiency. Adv Biochem Eng Biotechnol. 2013; 139:11-33. DOI: 10.1007/10_2013_260. View

Wang Q, Chen Y, Park J, Liu X, Hu Y, Wang T . Design and Production of Bispecific Antibodies. Antibodies (Basel). 2019; 8(3). PMC: 6783844. DOI: 10.3390/antib8030043. View

Ma J, Mo Y, Tang M, Shen J, Qi Y, Zhao W . Bispecific Antibodies: From Research to Clinical Application. Front Immunol. 2021; 12:626616. PMC: 8131538. DOI: 10.3389/fimmu.2021.626616. View

Almagro J, Pedraza-Escalona M, Arrieta H, Perez-Tapia S . Phage Display Libraries for Antibody Therapeutic Discovery and Development. Antibodies (Basel). 2019; 8(3). PMC: 6784186. DOI: 10.3390/antib8030044. View

Rajendra Y, Peery R, Hougland M, Barnard G, Wu X, Fitchett J . Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies. Biotechnol Prog. 2016; 33(2):469-477. DOI: 10.1002/btpr.2414. View

10.

Park Y, Gong S, Kim H, Kim G, Choi J, Ahn J . Development of a serum-free defined system employing growth factors for preantral follicle culture. Mol Reprod Dev. 2013; 80(9):725-33. DOI: 10.1002/mrd.22204. View

11.

Jensen O, Ansari S, Gebauer L, Muller S, Lowjaga K, Geyer J . A double-Flp-in method for stable overexpression of two genes. Sci Rep. 2020; 10(1):14018. PMC: 7441062. DOI: 10.1038/s41598-020-71051-5. View

12.

Karagiannis S, Josephs D, Bax H, Spicer J . Therapeutic IgE Antibodies: Harnessing a Macrophage-Mediated Immune Surveillance Mechanism against Cancer. Cancer Res. 2017; 77(11):2779-2783. DOI: 10.1158/0008-5472.CAN-17-0428. View

13.

Qin J, Wu X, Xia Z, Huang Z, Zhang Y, Wang Y . The effect of hyperosmolality application time on production, quality, and biopotency of monoclonal antibodies produced in CHO cell fed-batch and perfusion cultures. Appl Microbiol Biotechnol. 2018; 103(3):1217-1229. DOI: 10.1007/s00253-018-9555-7. View

14.

De Cecco M, Galbraith D, McDermott L . What makes a good antibody-drug conjugate?. Expert Opin Biol Ther. 2021; 21(7):841-847. DOI: 10.1080/14712598.2021.1880562. View

15.

Lim S, Pyo K, Soo R, Cho B . The promise of bispecific antibodies: Clinical applications and challenges. Cancer Treat Rev. 2021; 99:102240. DOI: 10.1016/j.ctrv.2021.102240. View

16.

Kaplon H, Reichert J . Antibodies to watch in 2021. MAbs. 2021; 13(1):1860476. PMC: 7833761. DOI: 10.1080/19420862.2020.1860476. View

17.

Combe M, Sokolenko S . Quantifying the impact of cell culture media on CHO cell growth and protein production. Biotechnol Adv. 2021; 50:107761. DOI: 10.1016/j.biotechadv.2021.107761. View

18.

Budge J, Knight T, Povey J, Roobol J, Brown I, Singh G . Data for engineering lipid metabolism of Chinese hamster ovary (CHO) cells for enhanced recombinant protein production. Data Brief. 2020; 29:105217. PMC: 7013132. DOI: 10.1016/j.dib.2020.105217. View

19.

Rath T, Baker K, Dumont J, Peters R, Jiang H, Qiao S . Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics. Crit Rev Biotechnol. 2013; 35(2):235-54. PMC: 4876602. DOI: 10.3109/07388551.2013.834293. View

20.

Klingler J, Weiss S, Itri V, Liu X, Oguntuyo K, Stevens C . Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2. medRxiv. 2020; . PMC: 7654883. DOI: 10.1101/2020.08.18.20177303. View